PharmaTimesNews & Politicsnews

Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026

Tuesday, April 28, 2026John PinchingView original

Lead asset shows systemic, dose‑dependent anti‑tumour activity

Read the full article on the original site.

Read Full Article